These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30915713)

  • 21. Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition.
    Rogemond V; Auger C; Giraudon P; Becchi M; Auvergnon N; Belin MF; Honnorat J; Moradi-Améli M
    J Biol Chem; 2008 May; 283(21):14751-61. PubMed ID: 18332147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulatory and enzymatic functions of CRMPs in neuritogenesis, synaptic plasticity, and gene transcription.
    Hou ST
    Neurochem Int; 2020 Oct; 139():104795. PubMed ID: 32652266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on CRMP2 SUMOylation-deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic pain.
    Moutal A; Cai S; Yu J; Stratton HJ; Chefdeville A; Gomez K; Ran D; Madura CL; Boinon L; Soto M; Zhou Y; Shan Z; Chew LA; Rodgers KE; Khanna R
    Pain; 2020 Nov; 161(11):2629-2651. PubMed ID: 32569093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of CRMP2 in Regulation of Mitochondrial Morphology and Motility in Huntington's Disease.
    Brustovetsky T; Khanna R; Brustovetsky N
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia.
    Nomoto M; Konopaske GT; Yamashita N; Aoki R; Jitsuki-Takahashi A; Nakamura H; Makihara H; Saito M; Saigusa Y; Nakamura F; Watanabe K; Baba T; Benes FM; Tobe BTD; Pernia CD; Coyle JT; Sidman RL; Hirayasu Y; Snyder EY; Goshima Y
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34330827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Ubc9-Induced CRMP2 SUMOylation Disrupts Glioblastoma Cell Proliferation.
    Wang L; Ji S
    J Mol Neurosci; 2019 Nov; 69(3):391-398. PubMed ID: 31267313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice.
    Muha V; Williamson R; Hills R; McNeilly AD; McWilliams TG; Alonso J; Schimpl M; Leney AC; Heck AJR; Sutherland C; Read KD; McCrimmon RJ; Brooks SP; van Aalten DMF
    Open Biol; 2019 Nov; 9(11):190192. PubMed ID: 31771416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic inhibition of CRMP2 phosphorylation at serine 522 promotes axonal regeneration after optic nerve injury.
    Kondo S; Takahashi K; Kinoshita Y; Nagai J; Wakatsuki S; Araki T; Goshima Y; Ohshima T
    Sci Rep; 2019 May; 9(1):7188. PubMed ID: 31076621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-SUMOylated CRMP2 decreases Na
    Gomez K; Ran D; Madura CL; Moutal A; Khanna R
    Mol Brain; 2021 Jan; 14(1):20. PubMed ID: 33478555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases.
    Williamson R; van Aalten L; Mann DM; Platt B; Plattner F; Bedford L; Mayer J; Howlett D; Usardi A; Sutherland C; Cole AR
    J Alzheimers Dis; 2011; 27(3):615-25. PubMed ID: 21860090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collapsin response mediator protein 2 is involved in regulating breast cancer progression.
    Shimada K; Ishikawa T; Nakamura F; Shimizu D; Chishima T; Ichikawa Y; Sasaki T; Endo I; Nagashima Y; Goshima Y
    Breast Cancer; 2014 Nov; 21(6):715-23. PubMed ID: 23381229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization.
    Wilson SM; Xiong W; Wang Y; Ping X; Head JD; Brittain JM; Gagare PD; Ramachandran PV; Jin X; Khanna R
    Neuroscience; 2012 May; 210():451-66. PubMed ID: 22433297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
    Cole AR; Noble W; van Aalten L; Plattner F; Meimaridou R; Hogan D; Taylor M; LaFrancois J; Gunn-Moore F; Verkhratsky A; Oddo S; LaFerla F; Giese KP; Dineley KT; Duff K; Richardson JC; Yan SD; Hanger DP; Allan SM; Sutherland C
    J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for CRMP2-induced axonal microtubule formation.
    Niwa S; Nakamura F; Tomabechi Y; Aoki M; Shigematsu H; Matsumoto T; Yamagata A; Fukai S; Hirokawa N; Goshima Y; Shirouzu M; Nitta R
    Sci Rep; 2017 Sep; 7(1):10681. PubMed ID: 28878401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional protein kinase Cβ-mediated phosphorylation inhibits collapsin response-mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke-induced mice.
    Yang X; Zhang X; Li Y; Han S; Howells DW; Li S; Li J
    J Neurochem; 2016 May; 137(3):446-59. PubMed ID: 26788931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of CRMP2 is required for migration and positioning of Purkinje cells: Redundant roles of CRMP1 and CRMP4.
    Yamazaki Y; Nagai J; Akinaga S; Koga Y; Hasegawa M; Takahashi M; Yamashita N; Kolattukudy P; Goshima Y; Ohshima T
    Brain Res; 2020 Jun; 1736():146762. PubMed ID: 32156571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization.
    Yamashita N; Ohshima T; Nakamura F; Kolattukudy P; Honnorat J; Mikoshiba K; Goshima Y
    J Neurosci; 2012 Jan; 32(4):1360-5. PubMed ID: 22279220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tat-collapsin response mediator protein 2 (CRMP2) increases the survival of neurons after NMDA excitotoxity by reducing the cleavage of CRMP2.
    Yin Y; Wang Y; Chen L; Han S; Zhao L; Luo Y; Li J
    Neurochem Res; 2013 Oct; 38(10):2095-104. PubMed ID: 23907512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.